0 0 0 0 0 0 0.00614754098360661 0.00614754098360661
Sign Up Today X
Thanks for submitting the form.
Stockreport

Henry Schein (HSIC) Valuation Check After Exclusive CitoCBC Distribution Agreement [Yahoo! Finance]

Henry Schein, Inc. (HSIC)  More Company Research Source: Yahoo! Finance
Last henry schein, inc. earnings: 2/20 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: phx.corporate-ir.net/phoenix.zhtml?c=74322&p=irol-irhome
Henry Schein (HSIC) stock is in focus after the company secured exclusive U.S. distribution rights for CytoChip's FDA-cleared CitoCBC system, the first cartridge-based CBC device with a CLIA Waiver for point-of-care testing. See our latest analysis for Henry Schein. Investors have reacted positively to the CitoCBC agreement and recent M&A commentary, with the share price up 23.98% over the past 90 days and a 1-year total shareholder return of 8.82%. This suggests improving momentum after a softer 3-year period. If this kind of healthcare diagnostics story interests you, it could be a good moment to broaden your watchlist with healthcare stocks beyond Henry Schein. With the shares now at $78.08 and trading slightly above the average analyst price target, yet screening with a high internal value score and a large modeled intrinsic discount, is there still an opportunity here, or is the market already pricing in future growth? Henry Schein's most followed narrative pegs fair v [Read more]
IMPACT SNAPSHOT EVENT TIME: HSIC
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
HSIC alerts
from News Quantified
HSIC
NEWS
HSIC
Earnings
HSIC
Analyst Actions
HSIC
SEC Filings
Stockreport

Henry Schein (HSIC) Valuation Check After Exclusive CitoCBC Distribution Agreement [Yahoo! Finance]

Henry Schein, Inc.  (HSIC) 
More Company Research Source: Yahoo! Finance
Last henry schein, inc. earnings: 2/20 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: phx.corporate-ir.net/phoenix.zhtml?c=74322&p=irol-irhome
Henry Schein (HSIC) stock is in focus after the company secured exclusive U.S. distribution rights for CytoChip's FDA-cleared CitoCBC system, the first cartridge-based CBC device with a CLIA Waiver for point-of-care testing. See our latest analysis for Henry Schein. Investors have reacted positively to the CitoCBC agreement and recent M&A commentary, with the share price up 23.98% over the past 90 days and a 1-year total shareholder return of 8.82%. This suggests improving momentum after a softer 3-year period. If this kind of healthcare diagnostics story interests you, it could be a good moment to broaden your watchlist with healthcare stocks beyond Henry Schein. With the shares now at $78.08 and trading slightly above the average analyst price target, yet screening with a high internal value score and a large modeled intrinsic discount, is there still an opportunity here, or is the market already pricing in future growth? Henry Schein's most followed narrative pegs fair v [Read more]
IMPACT SNAPSHOT
EVENT TIME:
HSIC
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS